Market Tracker

06/30 6:16am ET

Fibrocell Science Inc (NASDAQ:FCSC)

1.13
Delayed Data
As of Jun 29
 -0.06 / -5.04%
Today’s Change
0.91
Today|||52-Week Range
7.60
-75.16%
Year-to-Date
Integra Life Sciences Forges Ahead with Expansion Plans
Jun 28 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for June 28th
Jun 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.19
Today’s open1.23
Day’s range1.11 - 1.25
Volume373,650
Average volume (3 months)330,990
Market cap$52.2M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-22.23%
Earnings growth (this year)+47.35%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+173.33%
P/E ratioNM
Price/Sales391.66
Price/Book3.68

Competitors

 Today’s
change
Today’s
% change
RNVARennova Health Inc+0.00+0.76%
RPBIFResponse Biomedical ...0.000.00%
CLDXCelldex Therapeutics...+0.07+1.61%
MGMistras Group Inc+0.19+0.83%
Data as of 06/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$492.0K
Annual profit (last year)-$34.5M
Net profit margin-7,002.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David M. Pernock
CFO, Treasurer &
Senior Vice President
Keith Alan Goldan
Corporate headquarters
Exton, Pennsylvania

Forecasts